Cefaclor: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Cefaclor}}
{{Cefaclor}}
{{CMG}}
{{CMG}}; {{AE}} {{SS}}


==Overview==
==Overview==
Line 7: Line 7:


==Category==
==Category==
Cephalosporin,Second-Generation
 
Cephalosporin, Second-Generation
 
==US Brand Names==
==US Brand Names==


Line 13: Line 15:


==FDA Package Insert==
==FDA Package Insert==
'''[[Cefaclor description|Description]]'''
 
''' [[Cefaclor description|Description]]'''
'''| [[Cefaclor clinical pharmacology|Clinical Pharmacology]]'''
'''| [[Cefaclor clinical pharmacology|Clinical Pharmacology]]'''
'''| [[Cefaclor microbiology|Microbiology]]'''
'''| [[Cefaclor microbiology|Microbiology]]'''
Line 26: Line 29:
'''| [[Cefaclor labels and packages|Labels and Packages]]'''
'''| [[Cefaclor labels and packages|Labels and Packages]]'''


==Mechanisms of Action==
==Mechanism of Action==


Cephalosporins disrupt the synthesis of the [[peptidoglycan]] layer of bacterial [[cell wall]]s.  The peptidoglycan layer is important for cell wall structural integrity, especially in [[Gram-positive]] organisms. The final transpeptidation step in the synthesis of the peptidoglycan is facilitated by [[transpeptidase]]s known as [[penicillin binding protein]]s (PBPs).
Cephalosporins disrupt the synthesis of the [[peptidoglycan]] layer of bacterial [[cell wall]]s.  The peptidoglycan layer is important for cell wall structural integrity, especially in [[Gram-positive]] organisms. The final transpeptidation step in the synthesis of the peptidoglycan is facilitated by [[transpeptidase]]s known as [[penicillin binding protein]]s (PBPs).

Revision as of 23:12, 5 January 2014

Cefaclor
CECLOR® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Overview

Cefaclor, also known as cefachlor or cefaclorum (brand names Ceclor, Distaclor, Keflor, Raniclor), is a second-generation cephalosporin antibiotic used to treat certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections.

Category

Cephalosporin, Second-Generation

US Brand Names

CECLOR®

FDA Package Insert

Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages

Mechanism of Action

Cephalosporins disrupt the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The final transpeptidation step in the synthesis of the peptidoglycan is facilitated by transpeptidases known as penicillin binding proteins (PBPs).

References